Impact of COVID-19 on new pharmacotherapy for insomnia: A matched cohort study using the national insurance claims database in Japan.

Key Points

• To assess the effect of COVID-19 on the initiation of insomnia medication in Japan.
• Utilized a national insurance claims database
• Conducted a matched cohort study design
• Compared medication initiation rates before and after COVID-19
• Found a significant rise in insomnia medication initiation post-COVID-19
• Emphasized the need for enhanced mental health support due to increased medication use